Web Analytics

Investor Profile

Catalio Capital Management

Catalio Capital Management United States - New York, NY
INVESTOR

1 Disclosed Funding Rounds $89,000,000
23 Participating Investments




Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Managem

Invested In

Company Date Round Raised
  Avalyn Pharma Inc. September, 28 ,2023 Series C $175,000,000
  xilis July, 13 ,2022 Series A $89,000,000
  Iambic Therapeutics October, 06 ,2023 Series B $100,000,000
  Ensoma February, 06 ,2023 Series B $85,000,000
  Odyssey Therapeutics December, 06 ,2023 Series C $101,000,000
  Volastra Therapeutics March, 08 ,2023 Series A $60,000,000
  Lassen Therapeutics December, 21 ,2023 Series B $85,000,000
  Septerna July, 18 ,2023 Series B $150,000,000
  NextPoint Therapeutics, Inc. February, 15 ,2024 Series B $42,500,000
  Georgiamune Inc. August, 10 ,2023 Series A $75,000,000
  FogPharma March, 05 ,2024 Series E $145,000,000
  Star Therapeutics September, 05 ,2023 Series C $90,000,000
  PinkDx, Inc. April, 26 ,2024 Series A $40,000,000
  NOETIK September, 08 ,2023 Seed $14,000,000
  INSIGHTEC June, 20 ,2024 Unknown $150,000,000
  Avalyn Pharma Inc. September, 28 ,2023 Series C $175,000,000
  Iambic Therapeutics October, 06 ,2023 Series B $100,000,000
  Odyssey Therapeutics December, 06 ,2023 Series C $101,000,000
  Lassen Therapeutics December, 21 ,2023 Series B $85,000,000
  NextPoint Therapeutics, Inc. February, 15 ,2024 Series B $42,500,000
  FogPharma March, 05 ,2024 Series E $145,000,000
  PinkDx, Inc. April, 26 ,2024 Series A $40,000,000
  INSIGHTEC June, 20 ,2024 Unknown $150,000,000